Lista de obras -

A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma

artículo científico publicado en 2021

AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma

artículo científico publicado en 2019

Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition

artículo científico publicado en 2017

Cancer associated fibroblasts and tumor growth: focus on multiple myeloma

artículo científico publicado en 2014

Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells.

artículo científico publicado en 2018

Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects

artículo científico publicado en 2018

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts

article

Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells.

artículo científico publicado en 2017

Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion.

artículo científico publicado en 2017

Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma

artículo científico publicado en 2016

Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity

artículo científico publicado en 2016

Kinome expression profiling to target new therapeutic avenues in multiple myeloma

artículo científico publicado en 2019

Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma

artículo científico publicado en 2017

Loss of RASSF4 expression in multiple myeloma promotes RAS-driven malignant progression.

artículo científico publicado en 2017

Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma

scientific article published on 18 November 2019

Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells

artículo científico publicado en 2015

Myeloid-derived suppressor cells as therapeutic target in hematological malignancies

artículo científico publicado en 2014

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

artículo científico publicado en 2018

Novel strategies to target the ubiquitin proteasome system in multiple myeloma

artículo científico publicado en 2016

RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

artículo científico publicado en 2016

The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic

artículo científico publicado en 2014

The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma

artículo científico publicado en 2019

The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

scientific article published on 15 May 2019

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.

artículo científico publicado en 2015

The genetic landscape of 5T models for multiple myeloma

artículo científico publicado en 2018

The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential

artículo científico publicado en 2016

Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.

artículo científico publicado en 2016

Lista de obras de

A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma

AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma

Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition

Cancer associated fibroblasts and tumor growth: focus on multiple myeloma

Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells.

Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts

Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells.

Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion.

Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma

Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity

Kinome expression profiling to target new therapeutic avenues in multiple myeloma

Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma

Loss of RASSF4 expression in multiple myeloma promotes RAS-driven malignant progression.

Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma

Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells

Myeloid-derived suppressor cells as therapeutic target in hematological malignancies

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

Novel strategies to target the ubiquitin proteasome system in multiple myeloma

RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic

The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma

The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.

The genetic landscape of 5T models for multiple myeloma

The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential

Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.